Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study

Journal of the American College of Cardiology

Volumn 68, Issue 9, 2016, Pages 934-945

  van der Laan, Sander W ^a   Fall, Tove ^b   Soumaré, Aicha ^c   Teumer, Alexander ^d,e   Sedaghat, Sanaz ^f   Baumert, Jens ^g   Zabaneh, Delilah ^h   van Setten, Jessica ^a   Isgum, Ivana ⁱ   Galesloot, Tessel E ^j   Arpegård, Johannes ^k,l   Amouyel, Philippe ^m,n   Trompet, Stella ^o   Waldenberger, Melanie ^g   Dörr, Marcus ^d,e   Magnusson, Patrik K ^l   Giedraitis, Vilmantas ^b   Larsson, Anders ^b   Morris, Andrew P ^p,q   Felix, Janine F ^f   Morrison, Alanna C ^r   Franceschini, Nora ^s   Bis, Joshua C ^t   Kavousi, Maryam ^f   O'Donnell, Christopher ^u,v   Drenos, Fotios ^h,w   Tragante, Vinicius ^a   Munroe, Patricia B ^x   Malik, Rainer ^y   Dichgans, Martin ^y,z   Worrall, Bradford B ^aa   Erdmann, Jeanette ^ab   Nelson, Christopher P ^ac,ad   Samani, Nilesh J ^ac,ad   Schunkert, Heribert ^e,ae   Marchini, Jonathan ^af   Patel, Riyaz S ^h,ag   Hingorani, Aroon D ^h   Lind, Lars ^b   Pedersen, Nancy L ^l   de Graaf, Jacqueline ^j   Kiemeney, Lambertus A L M ^j   Baumeister, Sebastian E ^d,ah   Franco, Oscar H ^f   Hofman, Albert ^f   Uitterlinden, André G ^f   Koenig, Wolfgang ^e,ae,ai   Meisinger, Christa ^g   Peters, Annette ^e,g   Thorand, Barbara ^g   Jukema, J Wouter ^o,aj   Eriksen, Bjørn Odvar ^ak,al   Toft, Ingrid ^al   Wilsgaard, Tom ^ak   Onland Moret, N Charlotte ^a   van der Schouw, Yvonne T ^a   Debette, Stéphanie ^c   Kumari, Meena ^am   Svensson, Per ^k,l   van der Harst, Pim ^aj,an   Kivimaki, Mika ^h   Keating, Brendan J ^ao   Sattar, Naveed ^ap   Dehghan, Abbas ^f   Reiner, Alex P ^aq   Ingelsson, Erik ^b,ar   den Ruijter, Hester M ^a   de Bakker, Paul I W ^a   Pasterkamp, Gerard ^a   Ärnlöv, Johan ^b   Holmes, Michael V ^as   Asselbergs, Folkert W ^a,h,aj   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l KAROLINSKA INSTITUTE   (Sweden)

^m UNIV LILLE   (France)

ⁿ INSTITUT PASTEUR DE LILLE   (France)

^o LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^p UNIVERSITY OF LIVERPOOL   (United Kingdom)

^q UNIVERSITY OF OXFORD   (United Kingdom)

^r UNIVERSITY OF TEXAS   (United States)

^s University of North Carolina at Chapel Hill   (United States)

^t UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^u Veterans Administration Boston Healthcare   (United States)

^v FRAMINGHAM HEART STUDY   (United States)

^w UNIVERSITY OF BRISTOL   (United Kingdom)

^x QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^y LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^z Technische Universität München Munich Cluster for Systems Neurology   (Germany)

^aa UNIVERSITY OF VIRGINIA   (United States)

^ab UNIVERSITY OF LÜBECK   (Germany)

^ac UNIVERSITY OF LEICESTER   (United Kingdom)

^ad GLENFIELD HOSPITAL   (United Kingdom)

^ae TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^af UNIVERSITY OF OXFORD   (United Kingdom)

^ag ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^ah UNIVERSITY OF REGENSBURG   (Germany)

^ai UNIVERSITY HOSPITAL ULM   (Germany)

^aj INTERUNIVERSITY CARDIOLOGY INSTITUTE OF THE NETHERLANDS   (Netherlands)

^ak UNIVERSITY OF TROMSØ   (Norway)

^al UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^am UNIVERSITY OF ESSEX   (United Kingdom)

^an UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^ao UNIVERSITY OF PENNSYLVANIA   (United States)

^ap UNIVERSITY OF GLASGOW   (United Kingdom)

^aq UNIVERSITY OF WASHINGTON   (United States)

^ar STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^as UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

coronary heart disease; genetics; heart failure; ischemic stroke

Indexed keywords

CYSTATIN C;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CST3 GENE; FEMALE; GENDER; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; QUANTITATIVE TRAIT LOCUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; GLOBAL HEALTH; INCIDENCE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES;

AGED; ALLELES; CARDIOVASCULAR DISEASES; CYSTATIN C; GENOTYPE; GLOBAL HEALTH; HUMANS; INCIDENCE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84995922824     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.05.092     Document Type: Article

References (46)

1. 1 Shi, G.P., Sukhova, G.K., Grubb, A., et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104 (1999), 1191–1197.
2. 2 Goddard, K.A.B., Olson, J.M., Payami, H., van der Voet, M., Kuivaniemi, H., Tromp, G., Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease. Neurogenetics 5 (2004), 121–128.
3. 3 Kaeser, S.A., Herzig, M.C., Coomaraswamy, J., et al. Cystatin C modulates cerebral beta-amyloidosis. Nat Genet 39 (2007), 1437–1439.
4. 4 Shlipak, M.G., Matsushita, K., Ärnlöv, J., et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369 (2013), 932–943.
5. 5 Shlipak, M.G., Sarnak, M.J., Katz, R., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 (2005), 2049–2060.
6. 6 Ni, L., Lü, J., Hou, L.B., et al. Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke 38 (2007), 3287–3288.
7. 7 Hoke, M., Amighi, J., Mlekusch, W., et al. Cystatin C and the risk for cardiovascular events in patients with asymptomatic carotid atherosclerosis. Stroke 41 (2010), 674–679.
8. 8 Ix, J.H., Chertow, G.M., Whooley, M.A., Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115 (2007), 173–179.
9. 9 Keller, T., Messow, C.M., Wild, P.S., et al. Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J 30 (2009), 314–320.
10. 10 Woitas, R.P., Kleber, M.E., Meinitzer, A., et al. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Atherosclerosis 229 (2013), 541–548.
11. 11 Parikh, N.I., Hwang, S.-J., Yang, Q., et al. Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study). Am J Cardiol 102 (2008), 1194–1198.
12. 12 Muntner, P., Mann, D., Winston, J., Bansilal, S., Farkouh, M.E., Serum cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. Am J Cardiol 102 (2008), 54–57.
13. 13 Melander, O., Newton-Cheh, C., Almgren, P., et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302 (2009), 49–57.
14. 14 Blankenberg, S., Zeller, T., Saarela, O., et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 121 (2010), 2388–2397.
15. 15 Arpegard, J., Viktorin, A., Chang, Z., de Faire, U., Magnusson, P.K.E., Svensson, P., Comparison of heritability of cystatin C- and creatinine-based estimates of kidney function and their relation to heritability of cardiovascular disease. J Am Heart Assoc, 4, 2014, e001467.
16. 16 Davey Smith, G., Ebrahim, S., “Mendelian randomization:” can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 32 (2003), 1–22.
17. 17 Chambers, J.C., Zhang, W., van der Harst, P., et al. Genetic loci influencing kidney function and chronic kidney disease. Nat Genet 42 (2010), 373–375.
18. 18 Köttgen, A., Pattaro, C., Böger, C.A., et al. New loci associated with kidney function and chronic kidney disease. Nat Genet 42 (2010), 376–384.
19. 19 Köttgen, A., Glazer, N.L., Dehghan, A., et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41 (2009), 712–717.
20. 20 Hwang, S.-J., A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet, 8, 2007, S10.
21. 21 Schunkert, H., König, I.R., Kathiresan, S., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43 (2011), 333–338.
22. 22 Traylor, M., Farrall, M., Holliday, E.G., et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 11 (2012), 951–962.
23. 23 The Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 43 (2011), 339–344.
24. 24 Smith, N.L., Felix, J.F., Morrison, A.C., et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Circ Cardiovasc Genet 3 (2010), 256–266.
25. 25 Lonsdale, J., Thomas, J., Salvatore, M., et al. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45 (2013), 580–585.
26. 26 Zeller, T., Wild, P.S., Schillert, A., et al. Genetics and beyond—the transcriptome of human monocytes and disease susceptibility. PLoS ONE, 5, 2009, e10693.
27. 27 Liang, L., Morar, N., Dixon, A.L., et al. A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res 23 (2013), 716–726.
28. 28 Grundberg, E., Small, K.S., Hedman, Å.K., et al. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet 44 (2012), 1084–1089.
29. 29 Higgins, J.P.T., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
30. 30 Burgess, S., Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol 43 (2014), 922–929.
31. 31 Bis, J.C., Kavousi, M., Franceschini, N., et al. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet 43 (2011), 940–947.
32. 32 van Setten, J., Isgum, I., Pechlivanis, S., et al. Serum lipid levels, body mass index, and their role in coronary artery calcification: a polygenic analysis. Circ Cardiovasc Genet 8 (2015), 327–333.
33. 33 Locke, A.E., Kahali, B., Berndt, S.I., et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518 (2015), 197–206.
34. 34 Shungin, D., Winkler, T.W., Croteau-Chonka, D.C., et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518 (2015), 187–196.
35. 35 Willer, C.J., Schmidt, E.M., Sengupta, S., et al., for the Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat Genet 45 (2013), 1274–1283.
36. 36 Dupuis, J., Langenberg, C., Prokopenko, I., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42 (2010), 105–116.
37. 37 Soranzo, N., Sanna, S., Wheeler, E., et al. Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes 59 (2010), 3229–3239.
38. 38 Voight, B.F., Scott, L.J., Morris, A.P., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42 (2010), 579–589.
39. 39 Liu, J.Z., Tozzi, F., Pillai, S.G., et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet 42 (2010), 436–440.
40. 40 Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 42 (2010), 441–447.
41. 41 Ganesh, S.K., Tragante, V., Guo, W., et al. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet 22 (2013), 1663–1678.
42. 42 Svensson-Färbom, P., Almgren, P., Hedblad, B., et al. Cystatin C is not causally related to coronary artery disease. PLoS ONE, 10, 2015, e0129269.
43. 43 Lawlor, D.A., Harbord, R.M., Sterne, J.A.C., Timpson, N., Davey-Smith, G., Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Statist Med 27 (2008), 1133–1163.
44. 44 Croteau-Chonka, D.C., Wu, Y., Li, Y., et al. Population-specific coding variant underlies genome-wide association with adiponectin level. Hum Mol Genet 21 (2011), 463–471.
45. 45 de Boer, R.A., Verweij, N., van Veldhuisen, D.J., et al. A genome-wide association study of circulating galectin-3. PLoS ONE, 7, 2011, e47385.
46. 46 Ioannidis, J.P.A., Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract 14 (2008), 951–957.